The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The efficacy and safety of neoadjuvant anti-PD-1 inhibitor combined with platinum-based chemotherapy in patients with potentially resectable non-small cell lung cancer.
 
Yongchang Zhang
No Relationships to Disclose
 
Liang Zeng
No Relationships to Disclose
 
Xiangyu Zhang
No Relationships to Disclose
 
Yuling Zhou
No Relationships to Disclose
 
Baihua Zhang
No Relationships to Disclose
 
Wenjuan Jiang
No Relationships to Disclose
 
Lin Guo
No Relationships to Disclose
 
Han Wang
No Relationships to Disclose
 
Xuan Gao
No Relationships to Disclose
 
Yan-Fang Guan
No Relationships to Disclose
 
Xuefeng Xia
No Relationships to Disclose
 
Tao Jiang
No Relationships to Disclose
 
Caicun Zhou
Honoraria - Boehringer Ingelheim; Hengrui Therapeutics; Innovent Biologics; Lilly; MSD; QiLu Pharmaceutical; Roche
Consulting or Advisory Role - Amoy Diagnostics; Hengrui Therapeutics; Innovent Biologics; QiLu Pharmaceutical
 
Nong Yang
No Relationships to Disclose